AJR F and L Medical Products: Radiation Protection & More
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Figures Only
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kawamoto, S.
Right arrow Articles by Fishman, E. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kawamoto, S.
Right arrow Articles by Fishman, E. K.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Hotlight (NEW!)
Right arrow
What's Hotlight?
AJR 2004; 183:915-921
© American Roentgen Ray Society


Abdominal Imaging

Lymphoplasmacytic Sclerosing Pancreatitis with Obstructive Jaundice: CT and Pathology Features

Satomi Kawamoto1, Stanley S. Siegelman1, Ralph H. Hruban2 and Elliot K. Fishman1

1 The Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins Hospital, 600 N Wolfe St., Baltimore, MD 21287.
2 Department of Pathology, Johns Hopkins Hospital, Baltimore, MD.

Received September 29, 2003; accepted after revision February 16, 2004.

 
Address correspondence to S. Kawamoto (skawamo1{at}jhmi.edu).


Abstract
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
 
OBJECTIVE. The clinical presentation of lymphoplasmacytic sclerosing pancreatitis (LPSP) can be very similar to that of pancreatic cancer, with no statistically significant differences in the rates of abdominal pain, weight loss, jaundice, or levels of carcinoembryonic agent or cancer antigen 19-9. The purpose of this study is to describe and illustrate the CT features of LPSP presenting with obstructive jaundice and to correlate CT and pathology findings.

MATERIALS AND METHODS. Five patients with LPSP were evaluated. Morphologic features of the pancreas on CT scans, including the size of the pancreas, presence or absence of a mass, segmental difference of contrast enhancement, pancreatic duct, major pancreatic vasculature, and biliary tract, were retrospectively evaluated and correlated with histopathology. The degree of contrast enhancement of the pancreas was compared in 10 patients without LPSP, who were scanned with the same protocol.

RESULTS. CT scans showed diffuse (n = 2) or focal (n = 3) enlargement of the pancreatic head. The normal lobular appearance of the pancreas was effaced, and the gland appeared featureless in the involved region. Enlarged areas showed an enhancement pattern similar to that of the rest of the pancreas, and no segmental difference of contrast enhancement was identified. Pancreatic duct dilatation was not seen in any patient. Thickening and contrast enhancement of the common bile duct wall (n = 4) and gallbladder wall (n = 3) were observed and were pathologically correlated with inflammatory infiltrate and fibrosis of the common bile duct (n = 3) and gallbladder (n = 1).

CONCLUSION. When these findings are encountered, further evaluation with serologic tests or biopsy may aid in the diagnosis of LPSP.


Introduction
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
 
Pancreaticoduodenectomy, also known as the Whipple procedure, is now a relatively safe procedure at centers of excellence with a low mortality rate and acceptable morbidity rate [1]. At leading centers, surgeons have espoused an aggressive approach to patients with putative periampullary malignancy, often eschewing biopsy before or during operation [2]. As a consequence, small numbers of patients (40/442 at Johns Hopkins [3], 29/603 at the Mayo Clinic [4], and 14/220 at the University of Amsterdam [5]) have Whipple procedures performed for benign disease that cannot be distinguished from cancer before surgery. Pancreatitis is the most common benign condition that mimics pancreatic cancer, and in recent experience at Johns Hopkins, lymphoplasmacytic sclerosing pancreatitis (LPSP) is the most common form of pancreatitis in patients who are subjected to pancreaticoduodenectomy for suspected cancer.

LPSP is a distinctive form of chronic pancreatitis characterized by a mixed inflammatory infiltrate that centers on the pancreatic ducts [3]. LPSP is also variously termed "nonalcoholic duct destructive chronic pancreatitis" [6], "sclerosing pancreatitis" or "sclerosing pancreatic cholangitis," and "autoimmune pancreatitis" [7, 8]. The pathogenesis of LPSP is unknown, but it is hypothesized to be a form of autoimmune pancreatitis. Yoshida et al. [7] reported unique features of this disorder, including increased serum {gamma}-globulin, presence of autoantibodies, absence of acute attacks of pancreatitis, diffuse enlargement of the pancreas, and diffuse irregular narrowing of the main pancreatic duct on endoscopic retrograde pancreatography. Occasional association with other autoimmune diseases such as Sjögren's disease, primary sclerosing cholangitis, and ulcerative colitis is made [7]. Most important, LPSP responds to steroid therapy, and pancreatic enlargement and diffuse narrowing of the pancreatic duct may resolve without surgical intervention [79].

Pathologically, the pancreas reveals dense lymphoplasmacytic infiltrates centered around the pancreatic ducts. A distinctive venulitis is also seen, and the inflammatory process also involves the biliary tree. Although LPSP shares the fibrosis and parenchymal atrophy that is characteristic of other forms of chronic pancreatitis such as ethanol-associated pancreatitis, LPSP lacks the parenchymal calcifications, pseudocysts, and fat necrosis that are commonly present in these other disorders [3, 10]. The morphologic alternations produced by LPSP may simulate malignancy: Masslike enlargement of the pancreatic head or irregular narrowing of the pancreatic duct mimics pancreatic cancer, and stricture of the common bile duct simulates primary bile duct malignancy.

We recently encountered five patients with LPSP who were referred to the radiology department for CT examination of suspected pancreatic malignancy and were treated with pancreaticoduodenectomy. The purpose of this article is to describe the CT features of LPSP, to correlate CT findings with histopathology, and to raise the consciousness of radiologists about the existence of an entity that is readily confused with periampullary malignancy.


Materials and Methods
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
 
Patient Population
This study was performed with institutional review board approval for review of images and records in patients with LPSP. Informed consent was not required.

Abdominal CT examinations, histopathologic results, and clinical records of five patients with LPSP after pancreaticoduodenectomy were reviewed. All patients were referred for abdominal CT examination for suspected pancreatic cancer from April 2002 to June 2003. Our study included three male and two female patients who were 51–71 years old (mean age, 61.0 years).

Clinically, all patients presented with obstructive jaundice. Of five patients, four had weight loss, three had abdominal pain, three had diarrhea, and one had nausea and vomiting. Two patients had elevated cancer antigen (CA) 19-9 levels. Pancreaticoduodenectomy was performed in the presence of a presumptive clinical diagnosis of malignant neoplasm of the pancreas, periampullary region, or common bile duct. None of these patients was clinically suspected to have autoimmune pancreatitis; therefore, none had been evaluated for serum autoimmune markers or received a trial of steroid therapy.

CT Examination
Four patients underwent CT examinations performed on a Somatom Volume Zoom scanner (Siemens Medical Solutions), and one, on a Sensation 16 scanner (Siemens Medical Solutions). The scans were obtained with a dual-phase acquisition that consisted of arterial phase images that began 25 sec after the initiation of contrast material injection and portal venous phase that began at approximately 55 sec after injection of 120 mL of iohexol (Omnipaque 350, Amersham Health) through a peripheral line at 3 mL/sec. For imaging of the pancreas and creating vascular maps, 4 x 1 mm or 16 x 0.75 mm detector collimation was used. For the diagnostic interpretation, axial images were reconstructed with a slice thickness and increment of 4 or 5 mm for arterial phase and venous phase imaging. Three-dimensional reconstruction was also reviewed on a freestanding Onyx Infinite Reality (Silicon Graphics) or Leonardo (Siemens Medical Solutions) workstation using a 1.25- or 0.75-mm slice thickness and a 1- or 0.75-mm reconstruction increment. Each patient ingested 1,000 mL of water over a 20-min period before scanning began. Other scanning parameters included 120 kVp, 125 mA, 1.25 collimation, and 0.5-sec rotation speed. All imaging data were reconstructed with the body soft-tissue algorithm.

Image Analysis
CT findings were retrospectively evaluated. The sizes of the head, body, and tail of the pancreas were subjectively assessed as small, normal, or enlarged. Quantitative assessment of Hounsfield units of the pancreas was determined by manually identifying the region of interest in the same area of the head, body, and tail of the pancreas on arterial and portal venous phases. The degree of contrast enhancement of each segment was calculated as

and compared with the degree of contrast enhancement of the pancreas using the Student's t test obtained in the same manner in 10 patients without LPSP scanned with the same protocol. Presence or absence of a discrete mass or segmental difference of contrast enhancement was evaluated on both arterial and venous phases. Dilatation, thickening, or contrast enhancement of the common bile duct and gallbladder, dilatation of the pancreatic duct, involvement of the major pancreatic vasculature, and presence of lymphadenopathy were also evaluated.


Results
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
 
Clinical Presentation
All five patients had obstructive jaundice and abdominal pain. Four patients had weight loss ranging from 10 to 40 lb (4.5–18.1 kg). Other symptoms included diarrhea in three patients and nausea and vomiting in one patient. The duration of symptoms was 2 weeks to 4 months. The level of CA 19-9 was elevated in two patients: 505 U/mL and 345 U/mL (normal range, 1.0–36.0 U/mL).

All patients were referred to our hospital with suspected neoplasm of the pancreatic head or periampullary region on CT (n = 5) or ERCP (n = 3) performed at another institution. ERCP of three patients showed stricture of the distal common bile duct. Two patients underwent endoscopic retrograde cholangiography or ERCP at our institution, and two patients underwent endoscopic sonography at our institution. ERCP of one patient showed a malignant-appearing stricture of the pancreatic duct in the head of the pancreas as well as a 1-cm-long tight stricture of the common bile duct approximately 2 mm in diameter in the area of the pancreatic head with moderate dilatation above it. Endoscopic retrograde cholangiography of the other patient showed a long, smooth stricture in the mid and lower common bile duct with dilatation above the stricture (Fig. 1A, 1B, 1C). Scattered foci of stenosis in the right hepatic ducts were also seen. The pancreatic duct was not cannulated in this patient. Results of endoscopic sonography of one patient were suspicious for a 1.6 x 2.2 cm mass in the pancreatic head with a 1.0 x 0.6 cm peripancreatic lymph node. Fine-needle aspiration of the mass under endoscopic sonography showed rare fragments of atypical pancreatic duct epithelium. Fine-needle aspiration of the lymph node was negative for neoplasm. On endoscopic sonography, the other patient also was suspected of having a 3 x 3 cm mass in the pancreatic head and thickening of the distal common bile duct. Fine-needle aspiration of this mass under endoscopic sonography showed fragments of ductal epithelium and fibrous tissue.



View larger version (129K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 1A. 63-year-old man with lymphoplasmacytic sclerosing pancreatitis and inflammation of common bile duct. Venous phase contrast-enhanced CT scans obtained at level of pancreatic body and tail (A) and pancreatic head (B) show diffuse enlargement of pancreas without discrete mass. Capsulelike rim of decreased attenuation is present around pancreas. Common bile duct stent had been placed. Mild gallbladder wall thickening and contrast enhancement are seen, but pathologically no evidence of inflammation is present.

 


View larger version (122K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 1B. 63-year-old man with lymphoplasmacytic sclerosing pancreatitis and inflammation of common bile duct. Venous phase contrast-enhanced CT scans obtained at level of pancreatic body and tail (A) and pancreatic head (B) show diffuse enlargement of pancreas without discrete mass. Capsulelike rim of decreased attenuation is present around pancreas. Common bile duct stent had been placed. Mild gallbladder wall thickening and contrast enhancement are seen, but pathologically no evidence of inflammation is present.

 


View larger version (131K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 1C. 63-year-old man with lymphoplasmacytic sclerosing pancreatitis and inflammation of common bile duct. Endoscopic retrograde cholangiogram shows long, smooth stricture in mid and lower common bile duct with dilatation above stricture. Scattered focal stenoses were also seen in right hepatic ducts.

 

Summary of CT Findings
CT findings of the five patients are summarized in Table 1. Two patients had diffuse enlargement of the pancreas (Figs. 1A, 1B, 1C and 2A, 2B, 2C, 2D, 2E, 2F), and three had more focal enlargement of the pancreatic head (Fig. 3A, 3B, 3C). However, none of the five patients showed a discrete mass or segmental difference of contrast enhancement. The usual lobular appearance of the pancreas was effaced, and the gland appeared featureless and had a relatively straight border in three patients. A typical capsulelike rim of low attenuation reported in the literature [11] was seen in two patients. Contrast enhancement of the pancreas was increased on the venous phase compared with the arterial phase in four patients and decreased in one patient, and average degree of contrast enhancement was 11.9% ± 18.5%. These results were compared with those of 10 patients without LPSP who were scanned with the same protocol and showed an increased degree of contrast enhancement on the venous phase compared with the arterial phase in eight patients and decreased in two patients; average degree of contrast enhancement was 14.9% ± 17.6% (p = 0.79). Therefore, the degree of contrast enhancement was not significantly different in patients with LPSP in our study population. In one patient, the splenic vein was minimally narrowed by an enlarged pancreatic tail and adjacent inflammation but was patent. Small lymph nodes up to 1 cm were seen in the porta hepatis, portocaval region, or peripancreatic region in two patients (Fig. 2A, 2B, 2C, 2D, 2E, 2F). None of these five patients showed dilatation of the main pancreatic duct or calcification of the pancreas. Thickening and contrast enhancement of the common bile duct were seen in four patients (Figs. 1A, 1B, 1C and 2A, 2B, 2C, 2D, 2E, 2F). Three of them had mixed infiltrates and fibrosis consistent with common bile duct disease associated with LPSP, but in one patient the specimen was unavailable for review. The fifth patient had pathologic evidence of common bile duct involvement, but CT assessment was compromised by pneumobilia. Mild to moderate gallbladder wall thickening and contrast enhancement were seen in four patients, and two patients had mixed infiltrates and fibrosis consistent with gallbladder disease associated with LPSP (Fig. 2A, 2B, 2C, 2D, 2E, 2F). Three patients also had cholelithiasis.


View this table:
[in this window]
[in a new window]

 
TABLE 1 CT and Pathology Findings in Five Patients with Lymphoplasmacytic Sclerosing Pancreatitis

 


View larger version (127K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 2A. 51-year-old man with lymphoplasmacytic sclerosing pancreatitis (LPSP) and inflammation of common bile duct and gallbladder. Arterial (A) and venous (B) phase contrast-enhanced CT scans at level of pancreatic body and tail show diffuse enlargement of pancreas. Capsulelike low-attenuation rim is seen around pancreas. No pancreatic duct dilatation is observed. Thickening and contrast enhancement of gallbladder and common bile duct are present. Common bile duct is dilated above intrapancreatic portion. Gallstone is partially visualized on arterial phase image.

 


View larger version (135K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 2B. 51-year-old man with lymphoplasmacytic sclerosing pancreatitis (LPSP) and inflammation of common bile duct and gallbladder. Arterial (A) and venous (B) phase contrast-enhanced CT scans at level of pancreatic body and tail show diffuse enlargement of pancreas. Capsulelike low-attenuation rim is seen around pancreas. No pancreatic duct dilatation is observed. Thickening and contrast enhancement of gallbladder and common bile duct are present. Common bile duct is dilated above intrapancreatic portion. Gallstone is partially visualized on arterial phase image.

 


View larger version (147K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 2C. 51-year-old man with lymphoplasmacytic sclerosing pancreatitis (LPSP) and inflammation of common bile duct and gallbladder. Venous phase CT scan obtained at level of main portal vein shows circumferential thickening and contrast enhancement of common bile duct (large arrow). Small lymph nodes are also seen in porta hepatis (small arrows).

 


View larger version (162K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 2D. 51-year-old man with lymphoplasmacytic sclerosing pancreatitis (LPSP) and inflammation of common bile duct and gallbladder. Anterior volume-rendered 3D reconstruction of CT image shows diffusely enlarged pancreas, particularly in head. Stenosis of intrapancreatic portion and dilatation of more superior portion of common bile duct are seen. Thickening and contrast enhancement of dilated common bile duct were seen above pancreas (arrow). Increased thickness and contrast enhancement of gallbladder are seen. Pathologically, dense mixed infiltrates and fibrosis in common bile duct and gallbladder are also present.

 


View larger version (152K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 2E. 51-year-old man with lymphoplasmacytic sclerosing pancreatitis (LPSP) and inflammation of common bile duct and gallbladder. Photomicrograph of surgical specimen of pancreas shows classic changes of LPSP involvement of pancreatic duct. Dense inflammatory infiltrates with associated fibrosis surrounds pancreatic duct. (H and E, x40)

 


View larger version (139K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 2F. 51-year-old man with lymphoplasmacytic sclerosing pancreatitis (LPSP) and inflammation of common bile duct and gallbladder. Photomicrograph of surgical specimen shows common bile duct with dense mixed infiltrate and fibrosis. (H and E, x64)

 


View larger version (136K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 3A. 63-year-old man with lymphoplasmacytic sclerosing pancreatitis and inflammation of common bile duct and gallbladder. Venous phase contrast-enhanced CT scans obtained at level of pancreatic head and body (A) and pancreatic head (B) show enlargement of head of pancreas without discrete mass. Pancreatic duct is not dilated. Common bile duct stent is in place. Subcapsular hematoma is seen along liver surface. Contrast material residue is seen in gallbladder lumen.

 


View larger version (135K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 3B. 63-year-old man with lymphoplasmacytic sclerosing pancreatitis and inflammation of common bile duct and gallbladder. Venous phase contrast-enhanced CT scans obtained at level of pancreatic head and body (A) and pancreatic head (B) show enlargement of head of pancreas without discrete mass. Pancreatic duct is not dilated. Common bile duct stent is in place. Subcapsular hematoma is seen along liver surface. Contrast material residue is seen in gallbladder lumen.

 


View larger version (133K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 3C. 63-year-old man with lymphoplasmacytic sclerosing pancreatitis and inflammation of common bile duct and gallbladder. Venous phase CT scan obtained at level of main portal vein shows circumferential thickening of common bile duct with increased contrast enhancement (arrow). Pathologically, common bile duct showed extensive fibrosis and lymphoplasmacytic infiltrate.

 

Surgery and Pathology Findings
Although these findings did not have the classic appearance of pancreatic cancer, the patients were clinically thought to have resectable pancreatic cancer. Specifically, in one patient, the diffuse enlargement of the gland was considered indicative of pancreatitis, probably secondary to a small tumor obstructing the pancreatic duct. In the other two patients, a mass was suspected in the pancreatic head on endoscopic sonography. Fine-needle aspiration under sonographic guidance was performed in these two patients, and the specimen from one of these two patients showed fragments of atypical pancreatic duct epithelium. All patients underwent pancreaticoduodenectomy.

At surgery, the pancreas was enlarged and extremely firm in all patients. Three patients with more focal enlargement of the pancreatic head had a hard mass in the head of the pancreas, but the remaining body and tail of the pancreas were also firm and hard in texture. Dense adherence between the pancreas and the structures of the retroperitoneum, the adjacent superior mesenteric vein, and the superior mesenteric artery was described in three patients.

Pathologically, the pancreas showed features typical of LPSP, including mixed inflammatory cell infiltrates centered around the pancreatic ducts (Fig. 2A, 2B, 2C, 2D, 2E, 2F) and venulitis, in all patients. One patient who had fragments of atypical pancreatic duct epithelium at fine-needle aspiration under endoscopic sonography had LPSP and focal pancreatic intraepithelial neoplasia [12], but no carcinoma was identified. The common bile duct showed dense mixed infiltrates and fibrosis in four patients (Fig. 2A, 2B, 2C, 2D, 2E, 2F). The gallbladder also showed mild mixed infiltrates and fibrosis in two patients (Table 1).

Four patients were doing well without abdominal pain after operation. One patient had occasional abdominal pain but has gained weight.


Discussion
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
 
Analysis of large series involving more than 1,200 patients who underwent pancreaticoduodenectomy revealed that 2.2–2.4% of the patients had pathologic features consistent with LPSP. All these patients had a presumed preoperative diagnosis of pancreatic cancer, periampullary neoplasm, or cholangiocarcinoma [13, 14]. Ito et al. [8] reported that among 161 patients with chronic pancreatitis evaluated with endoscopic retrograde pancreatography, three (1.86%) had autoimmune pancreatitis.

The clinical presentation of LPSP and pancreatic cancer can be very similar. Hardacre et al. [11] reported that no statistically significant differences in the rates of abdominal pain, weight loss, jaundice, or preoperative carcinoembryonic agent or CA 19-9 levels. Jaundice was seen in 84% of patients with LPSP who underwent pancreaticoduodenectomy [13]. Although a focal mass is the primary CT finding of a pancreatic adenocarcinoma, not all carcinomas present as masses. Differentiation between carcinoma and inflammatory disease can be difficult because the pancreas may be diffusely enlarged by a carcinoma-induced pancreatitis. In a certain percentage of cases, only surgically obtained histologic material will resolve this question. Because of recent improvement in the safety of pancreaticoduodenectomy and because of false-negative results from needle biopsy, particularly in patients who have the smallest lesions and the best likelihood of recovery, surgeons make a decision to proceed directly to resection without performing biopsy [2].

CT features of this form of pancreatitis have previously been reported in the literature [6, 9, 11]. Among 15 of these reported cases, 11 patients showed a diffusely enlarged pancreas and four patients had more focal enlargement. One patient had small calcifications in the head. Common bile duct stenosis or dilatation was described in six patients. The pancreatic duct is usually not dilated, but mild upstream dilatation of the main pancreatic duct was reported in four patients. Splenic vein occlusion was described in one patient, but no other vascular involvement was reported. A capsulelike low-attenuation rim that showed subtle delayed enhancement was described in four patients. Involved pancreatic parenchyma may show zones of decreased contrast enhancement with or without discrete margins on arterial or early phase images. When delayed phase images were acquired, the lesion showed increased contrast enhancement in seven of eight reported cases. However, the lesion may remain hypodense on delayed phase compared with relatively normal parenchyma [15]. Mass or masslike enlargement has been reported more commonly in the pancreatic head but may be seen in the body or tail [6]. The existence of multiple masses has also been reported [16]. In our five patients, no discrete mass or discrete area of different contrast enhancement was observed even with focal enlargement. No pancreatic duct dilatation was seen in our five patients.

Patients with LPSP have distal common bile duct fibrosis, strictures, and inflammation—features that overlap somewhat with primary sclerosing cholangitis. Abraham et al. [17] reported that among 20 patients with LPSP who were treated with pancreaticoduodenectomy, 12 (60%) had moderate or marked inflammatory infiltrates in the extrapancreatic common bile duct and 84.2% had moderate to marked inflammatory infiltrates in the intrapancreatic common bile duct. Most (60%) of the gallbladders in LPSP also contained moderate or marked inflammatory infiltrates and lymphoid nodules [17]. Abraham et al. concluded that gallbladder involvement in LPSP, similar to primary sclerosing cholangitis, is most commonly part of a spectrum of biliary tract disease that includes frequent distal strictures, fibrosis, and inflammation of the extrapancreatic or intrapancreatic common bile duct. Thickening of the gallbladder wall on CT scans has been described in a reported case [18].

Several CT features can be useful in differentiating LPSP from pancreatic cancer. The pancreatic duct usually shows diffuse or focal irregular narrowing in LPSP without significant dilatation, but it is usually dilated in patients with pancreatic ductal adenocarcinoma. Major pancreatic vascular involvement is uncommon in LPSP compared with pancreatic adenocarcinoma, although cases have been reported to involve the peripancreatic vessels [9]. One of our five patients also showed mild splenic vein narrowing. Atrophy of the pancreas proximal to duct obstruction is often seen in patients with pancreatic cancer, but LPSP usually is not manifest in detectable atrophy. Acinar parenchyma becomes atrophic in LPSP but is replaced with fibrous tissue [3], which explains why overall size of the gland does not change.

When the characteristic features of LPSP are observed on CT scans, the diagnosis of LPSP can be suggested. Procacci et al. [15] reported that dynamic CT findings can aid in making a correct diagnosis of autoimmune pancreatitis with 92.5% accuracy. They evaluated seven patients with proven autoimmune pancreatitis and 20 patients with other pancreatic diseases (acute or chronic pancreatitis and adenocarcinoma of the pancreas) using the following criteria: focal or diffuse enlargement; net hypodensity compared with the spleen and adjacent unaffected parenchyma on early (or arterial), late (or venous), or delayed contrastenhanced images; possible identification of a hypodense capsulelike rim; absence of calcification; possible stenosis or obstruction of the common bile duct at the pancreatic head; and possible stenosis or upstream dilatation of the main pancreatic duct. In these patients, immunologic tests for elevated IgG4 level may be helpful to confirm the diagnosis [19].

Findings of LPSP using other imaging techniques have been reported. On sonographic examination, the pancreas appears hypoechoic and diffusely enlarged with a so-called sausagelike appearance [8, 9] or as a hypoechoic mass in the affected site [6]. MRI may reveal diffuse pancreatic enlargement with hypointensity on T1-weighted images. The low-attenuation capsulelike rim described on CT is hypointense on T2-weighted images and shows delayed enhancement, suggesting fibrous tissue rather than a fluid collection or phlegmon [12]. ERCP may show diffuse narrowing and irregularity of the main pancreatic duct [8, 9] with nonvisualization of secondary branches. Gallium scintigraphy [20] and FDG PET [21] have been reported to show increased uptake in the affected site of the pancreas, which can be confused with malignancy.

In conclusion, LPSP is a unique clinical entity that is becoming more recognized in clinical practice. Because it responds to steroid therapy, early recognition is important to preclude surgery. CT features suggestive of LPSP include diffuse or focal enlargement of the pancreas, a rim of low attenuation surrounding the pancreas, absence of atrophy of the pancreas, or absence of significant pancreatic duct dilatation. Thickening and contrast enhancement of the common bile duct and the gallbladder may be observed, reflecting inflammatory disease of these structures associated with LPSP. When these CT findings are encountered, further evaluation with serologic tests or biopsy is justified.


References
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
 

  1. Yeo CJ, Cameron JL, Sohn TA, et al. Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: pathology, complications, and outcomes. Ann Surg1997; 226:248 –257[Medline]
  2. Farnell MB, Nagorney DM, Sarr MG. The Mayo clinic approach to the surgical treatment of adenocarcinoma of the pancreas. Surg Clin North Am 2001;81:611 –623[Medline]
  3. Abraham SC, Wilentz RE, Yeo CJ, et al. Pancreaticoduodenectomy (Whipple resections) in patients without malignancy: are they all `chronic pancreatitis'? Am J Surg Pathol 2003;27 : 110–120[Medline]
  4. Smith CD, Behrns KE, van Heerden JA, Sarr MG. Radical pancreatoduodenectomy for misdiagnosed pancreatic mass. Br J Surg 1994;81:585 –589[Medline]
  5. van Gulik TM, Reeders JW, Bosma A, et al. Incidence and clinical findings of benign, inflammatory disease in patients resected for presumed pancreatic head cancer. Gastrointest Endosc1997; 46:417 –423[Medline]
  6. Van Hoe L, Gryspeerdt S, Ectors N, et al. Nonalcoholic duct-destructive chronic pancreatitis: imaging findings. AJR 1998;170:643 –647[Abstract/Free Full Text]
  7. Yoshida K, Toki F, Takeuchi T, Watanabe S, Shiratori K, Hayashi N. Chronic pancreatitis caused by an autoimmune abnormality: proposal of the concept of autoimmune pancreatitis. Dig Dis Sci1995; 40:1561 –1568[Medline]
  8. Ito T, Nakano I, Koyanagi S, et al. Autoimmune pancreatitis as a new clinical entity: three cases of autoimmune pancreatitis with effective steroid therapy. Dig Dis Sci1997; 42:1458 –1468[Medline]
  9. Furukawa N, Muranaka T, Yasumori K, Matsubayashi R, Hayashida K, Arita Y. Autoimmune pancreatitis: radiologic findings in three histological proven cases. J Comput Assist Tomogr1998; 22:880 –883[Medline]
  10. Notohara K, Burgart LJ, Yadav D, Chari S, Smyrk TC. Idiopathic chronic pancreatitis with periductal lymphoplasmacytic infiltration: clinicopathologic features of 35 cases. Am J Surg Pathol 2003;27:1119 –1127[Medline]
  11. Hardacre JM, Iacobuzio-Donahue CA, Sohn TA, et al. Results of pancreaticoduodenectomy for lymphoplasmacytic sclerosing pancreatitis. Ann Surg 2003;237:853 –859[Medline]
  12. Hruban RH, Adsay NV, Albores-Saavedra J, et al. Pancreatic intraepithelial neoplasia: a new nomenclature and classification system for pancreatic duct lesions. Am J Surg Pathol2001; 25:579 –586[Medline]
  13. Weber SM, Cubukcu-Dimopulo O, Palesty JA, et al. Lymphoplasmacytic sclerosing pancreatitis: inflammatory mimic of pancreatic carcinoma. J Gastrointest Surg2003; 7:129 –137[Medline]
  14. Irie H, Honda, H, Baba S, et al. Autoimmune pancreatitis: CT and MR characteristics. AJR1998; 170:1323 –1327[Abstract/Free Full Text]
  15. Procacci C, Carbognin G, Biasiutti C, et al. Autoimmune pancreatitis: possibilities of CT characterization. Pancreatology2001; 1:246 –253[Medline]
  16. Ohana M, Okazaki K, Hajiro K, Kobashi Y. Multiple pancreatic masses associated with autoimmunity. Am J Gastroenterol1998; 93:99 –102[Medline]
  17. Abraham SC, Cruz-Correa M, Argani P, Furth EE, Hruban RH, Boitnott JK. Lymphoplasmacytic chronic cholecystitis and biliary tract disease in patients with lymphoplasmacytic sclerosing pancreatitis. Am J Surg Pathol 2003; 27:441 –451[Medline]
  18. Nikfarjam M, Muralidharan V, Christophi C, Tang H, Clouston D. Autoimmune pancreatitis. Aust N Z J Surg2002; 72:450 –452
  19. Hamano H, Kawa S, Horiuchi A, et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med2001; 344:732 –738[Abstract/Free Full Text]
  20. Horiuchi A, Kaneko T, Yamamura N, et al. Autoimmune chronic pancreatitis simulating pancreatic lymphoma. Am J Gastroenterol 1996;91:2607 –2609[Medline]
  21. Nakamoto Y, Saga T, Ishimori T, et al. FDG-PET of autoimmune-related pancreatitis: preliminary results. Eur J Nucl Med 2000;27:1835 –1838[Medline]

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Am. J. Roentgenol.Home page
N. Takahashi, J. G. Fletcher, D. M. Hough, J. L. Fidler, A. Kawashima, J. N. Mandrekar, and S. T. Chari
Autoimmune Pancreatitis: Differentiation From Pancreatic Carcinoma and Normal Pancreas on the Basis of Enhancement Characteristics at Dual-Phase CT
Am. J. Roentgenol., August 1, 2009; 193(2): 479 - 484.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
N. Takahashi, J. G. Fletcher, J. L. Fidler, D. M. Hough, A. Kawashima, and S. T. Chari
Dual-Phase CT of Autoimmune Pancreatitis: A Multireader Study
Am. J. Roentgenol., February 1, 2008; 190(2): 280 - 286.
[Abstract] [Full Text] [PDF]


Home page
RadioGraphicsHome page
S. Kawamoto, S. S. Siegelman, R. H. Hruban, and E. K. Fishman
Lymphoplasmacytic Sclerosing Pancreatitis (Autoimmune Pancreatitis): Evaluation with Multidetector CT
RadioGraphics, January 1, 2008; 28(1): 157 - 170.
[Abstract] [Full Text] [PDF]


Home page
RadioGraphicsHome page
S. Kim, N. K. Lee, J. W. Lee, C. W. Kim, S. H. Lee, G. H. Kim, and D. H. Kang
CT Evaluation of the Bulging Papilla with Endoscopic Correlation
RadioGraphics, July 1, 2007; 27(4): 1023 - 1038.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
D. Brennan and I. Pedrosa
Lymphoplasmacytic Sclerosing Pancreatitis
Am. J. Roentgenol., November 1, 2005; 185(5): 1367 - 1368.
[Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
S. Kawamoto and E. K. Fishman
Reply
Am. J. Roentgenol., November 1, 2005; 185(5): 1368 - 1368.
[Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Figures Only
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kawamoto, S.
Right arrow Articles by Fishman, E. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kawamoto, S.
Right arrow Articles by Fishman, E. K.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Hotlight (NEW!)
Right arrow
What's Hotlight?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS